Please assess the completion status of the following clinical trial:

Trial Title: Tetracycline (Doxycycline) and Post Myocardial Infarction Remodeling

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: PHASE2
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Acute myocardial infarction~* Left ventricular ejection fraction less than 40%~Exclusion Criteria:~* No written consensus~* Allergy to tetracycline~* Mechanical complication of AMI~* Previous myocardial infarction~* Valvular and/or myocardiopathy known or suspected~* Renal failure (creatinine above 2 mg/dL)~* Connective tissue disease~* Pregnancy

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- Doxycycline (Type: EXPERIMENTAL): Active drug 100 mg bid for seven days in pts with AMI treated with Primary PCI and current medical therapy
- Standard Therapy (Type: ACTIVE_COMPARATOR): Pts with AMI treated with Primary PCI and current medical therapy

Based on this trial design, predict the completion outcome and termination type (if applicable).